Bicistronic	O
retroviral	O
vector	O
reveals	O
capacity	O
of	O
v	O
-	O
erbA	O
to	O
induce	O
erythroleukemia	B-Cancer
and	O
to	O
co	O
-	O
operate	O
with	O
v	O
-	O
myb	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
v	O
-	O
erbA	O
and	O
v	O
-	O
myb	O
can	O
induce	O
the	O
proliferation	O
of	O
avian	O
erythroid	B-Cell
cells	I-Cell
in	O
culture	O
.	O

To	O
study	O
the	O
combined	O
effects	O
of	O
v	O
-	O
erbA	O
and	O
v	O
-	O
myb	O
,	O
the	O
two	O
oncogenes	O
were	O
engineered	O
into	O
a	O
retrovirus	O
bicistronic	O
vector	O
with	O
an	O
internal	O
ribosomal	B-Cellular_component
entry	O
site	O
(	O
IRES	O
)	O
or	O
into	O
a	O
vector	O
with	O
a	O
splice	O
acceptor	O
(	O
SPL	O
)	O
.	O

This	O
allowed	O
coexpression	O
of	O
the	O
two	O
proteins	O
and	O
a	O
comparison	O
with	O
the	O
same	O
vector	O
containing	O
either	O
v	O
-	O
erbA	O
or	O
v	O
-	O
myb	O
only	O
.	O

Both	O
the	O
erbA	O
IRES	O
and	O
the	O
erbA	O
/	O
myb	O
IRES	O
virus	O
constructs	O
transformed	O
erythroid	B-Cell
cells	I-Cell
after	O
infection	O
of	O
bone	B-Multi-tissue_structure
marrow	I-Multi-tissue_structure
or	O
blastoderm	B-Cell
cultures	I-Cell
.	O

The	O
erbA	O
/	O
myb	O
IRES	O
virus	O
exhibited	O
a	O
5	O
-	O
10	O
-	O
fold	O
higher	O
transformed	O
colony	B-Cell
forming	O
efficiency	O
than	O
the	O
erbA	O
IRES	O
virus	O
in	O
the	O
blastoderm	B-Cell
assay	O
.	O

Surprisingly	O
,	O
when	O
injected	O
into	O
chicken	O
embryos	B-Developing_anatomical_structure
in	O
the	O
presence	O
of	O
helper	O
virus	O
,	O
both	O
viruses	O
induced	O
an	O
erythroleukemia	B-Cancer
in	O
about	O
half	O
of	O
the	O
animals	O
.	O

In	O
contrast	O
,	O
no	O
leukemia	B-Cancer
was	O
observed	O
with	O
a	O
myb	O
IRES	O
virus	O
,	O
with	O
spliced	O
vectors	O
containing	O
v	O
-	O
erbA	O
alone	O
or	O
v	O
-	O
erbA	O
in	O
combination	O
with	O
v	O
-	O
myb	O
,	O
nor	O
with	O
erbA	O
IRES	O
and	O
erbA	O
/	O
myb	O
IRES	O
viruses	O
produced	O
in	O
the	O
absence	O
of	O
helper	O
virus	O
.	O

The	O
average	O
latency	O
of	O
leukemia	B-Cancer
induction	O
was	O
shorter	O
for	O
the	O
erbA	O
/	O
myb	O
IRES	O
virus	O
(	O
3	O
.	O
5	O
weeks	O
)	O
than	O
for	O
the	O
erbA	O
IRES	O
virus	O
(	O
5	O
weeks	O
)	O
.	O

Nevertheless	O
,	O
for	O
both	O
viruses	O
the	O
leukemic	B-Cell
blasts	I-Cell
retained	O
full	O
factor	O
dependence	O
for	O
growth	O
.	O

These	O
results	O
show	O
that	O
v	O
-	O
erbA	O
is	O
capable	O
of	O
inducing	O
an	O
erythroleukemia	B-Cancer
when	O
expressed	O
by	O
a	O
high	O
titer	O
bicistronic	O
retrovirus	O
under	O
conditions	O
of	O
virus	O
spreading	O
and	O
that	O
its	O
in	O
vitro	O
and	O
in	O
vivo	O
transforming	O
potential	O
can	O
be	O
enhanced	O
by	O
v	O
-	O
myb	O
.	O

